The authoritative source for research information and outputs is Elsevier Scopus, with researcher profile verification from the Deanship of Scientific Research.
المخرجات
Research outputs
Articles, reviews, conference papers and book chapters, indexed by DOI and linked to University researchers.
Health Services Insights · vol. 19 · 11786329261450733-11786329261450733
Introduction: The yearly observance of Ramadan, which includes prolonged daily fasting, presents a challenging scenario for patients with chronic illnesses, with existing studies presenting inconsistent findings on its metabolic implications. Objective: This study aimed to objectively measure the immediate and sustained impacts of Ramadan fasting on monthly mean Hemoglobin A1c (HbA1c), Systolic Blood Pressure (SBP), and Diastolic Blood Pressure (DBP) in a large, real-world cohort of Saudi Arabian patients with concomitant T2DM and HTN. Methods: A retrospective longitudinal study was carried out using electronic health record (EHR) data from a Saudi multi-facility healthcare system from December 2023 to May 2024. The analysis used a segmented regression for Interrupted Time Series (ITS) to estimate changes in outcomes, with Ramadan (March 2024) serving as the intervention point. Results: = .002), indicating a rebound impact. The reduction in SBP was not sustained, as it returned to pre-Ramadan levels in the months that followed. Conclusions: In this large Saudi cohort, Ramadan fasting was linked to transitory improvements in glycemic and blood pressure control. The ensuing rebound implies that, while fasting can be metabolically advantageous, the effects do not last without ongoing intervention. These results highlight the important necessity for rigorous post-Ramadan clinical follow-up to consolidate any gains made during the fasting period. These findings position Ramadan as a novel window for metabolic reset and a potential preventive opportunity against cardiorenal metabolic syndrome progression in high-risk populations.
Ramadan fastingtype 2 diabeteshypertensionglycemic control
Background Thrombocytopenia is a common hematological disorder encountered in clinical practice. To improve diagnostic efficiency and patient outcomes, it is important to understand its frequent clinical manifestations and predominant etiologies in different healthcare settings. This study aimed to describe the typical clinical presentations and underlying causes of thrombocytopenia among patients at a tertiary care hospital in the Kingdom of Saudi Arabia. Study design A single-center, retrospective cross-sectional study. Materials and methods Patients with thrombocytopenia (platelet count < 150,000/microL) admitted between January and December 2022 were included. Patients with pseudothrombocytopenia were excluded. Demographic, clinical, and laboratory data were collected through manual review of electronic medical records. Etiologies were recorded, and statistical analysis was performed using Stata software. Here and throughout, n denotes the number of patients contributing data to a given comparison, and N denotes the total cohort (N = 114). Where applicable, denominators were adjusted for missing data. Results Of 114 patients, 73 (64.04%) were male. The mean age was 40.80 ± 15.93 years, and the mean length of hospital stay was 11.83 ± 15.73 days. The mean platelet count was 51,480 ± 39,690/microL. Mild thrombocytopenia was observed in 19 (16.67%) patients, moderate in 31 (27.19%), and severe in 64 (54.14%). Infection was the most common etiology (n = 48, 42.11%), with Plasmodium species accounting for the largest number of cases (n = 25). Bleeding manifestations were observed in 72 (63.07%) patients, most commonly epistaxis (n = 16, 14.04%), ecchymosis (n = 13, 11.4%), and petechiae (n = 9, 7.89%). Patients with bleeding, particularly petechiae, ecchymosis, epistaxis, and gum bleeding, had significantly lower platelet counts than those without bleeding symptoms. Conclusion Infections were the predominant cause of thrombocytopenia in this cohort. Lower platelet counts were significantly associated with bleeding manifestations, particularly epistaxis, emphasizing the need for early recognition and appropriate clinical management.
BACKGROUND: Given the rising incidence of endometrial cancer in Saudi Arabia, the integration of high-cost therapeutics, such as dostarlimab (DSR), for primary advanced or recurrent (pA/rEC) disease necessitates rigorous economic appraisal. Therefore, this study aimed to evaluate the cost-utility of first-line dostarlimab plus carboplatin-paclitaxel (DSR + CP) versus placebo plus carboplatin-paclitaxel (PBO + CP) from the perspective of the Saudi healthcare payer. METHODS: A partitioned survival model was constructed to simulate patient prognosis across three health states: progression-free disease, progressive disease, and death. The model parameters were derived from the clinical efficacy data of the RUBY trial and the local cost inputs. The primary outcome was the incremental cost-effectiveness ratio (ICER), the robustness of which was evaluated via comprehensive deterministic and probabilistic sensitivity analyses to characterize parameter uncertainty. RESULTS: For the overall pA/rEC population, the DSR + CP regimen yielded an incremental 1.55 quality-adjusted life-years (QALYs) at an additional cost of $144,716, resulting in an ICER of $93,244 per QALY. Cost-effectiveness was more favorable in the mismatch repair deficient (dMMR) subgroup (ICER: $82,754/QALY) than in the mismatch repair proficient (pMMR) cohort (ICER: $132,571/QALY). The ICER is the most sensitive to the acquisition cost of the DSR. At a willingness-to-pay threshold of $90,000/QALY, the probability of DSR + CP being cost-effective was 83.9% for the dMMR subgroup. CONCLUSION: This economic evaluation indicates that DSR + CP constitutes a cost-effective intervention for pA/rEC within the dMMR subpopulation. These findings provide strong evidence for a tailored reimbursement policy that effectively utilizes resources by connecting clinical benefits with economic value in the management of pA/rEC.
Caroli's disease (CD) and Caroli's syndrome (CS) are rare congenital fibropolycystic liver disorders. While CS is known to be associated with more severe hepatic complications than isolated CD, direct longitudinal comparisons between the two entities remain limited due to their rarity. This single-center, retrospective, longitudinal observational cohort study descriptively compared clinical features, complications, and long-term outcomes in 19 patients diagnosed with CD (n = 7) or CS (n = 12) between November 2015 and December 2022. Diagnoses were confirmed by magnetic resonance cholangiopancreatography. Patients underwent standardized clinical, laboratory, endoscopic, and imaging assessments during follow-up. Outcomes included recurrent cholangitis, portal hypertension-related complications, hepatic decompensation, cholangiocarcinoma, and all-cause mortality. Statistical analyses were descriptive and exploratory. Patients with CS exhibited more frequent portal hypertension, lower platelet counts, higher bilirubin and international normalized ratio levels, and lower serum albumin compared with patients with CD. All cases of esophageal varices, hepatic decompensation, cholangiocarcinoma (n = 3), and death (n = 3) occurred exclusively in the CS group. Exploratory analyses demonstrated monotonic associations between adverse outcomes and higher aspartate aminotransferase levels, increased frequency of cholangitis episodes, thrombocytopenia, and elevated CA 19 - 9 levels. Kaplan-Meier analysis showed shorter median survival in CS compared with CD (45.0 vs. 59.0 months; log-rank p = 0.020), which should be interpreted descriptively given the limited sample size. In this descriptive longitudinal cohort, Caroli's syndrome was associated with a more severe clinical course and poorer outcomes than isolated Caroli's disease, consistent with existing literature. These findings provide detailed comparative outcome data and highlight clinically relevant patterns that may inform surveillance strategies and guide future multicentre, hypothesis-driven studies.
Background: Fournier’s gangrene is a rapidly progressive infection requiring coordinated emergency diagnosis, resuscitation, antimicrobial treatment, and surgical source control. Early manifestations overlap with less severe perineal infections, creating substantial diagnostic uncertainty. This review examined diagnostic and management evidence relevant to emergency department practice. Methods: Publications available through 31/05/2026 were evaluated using an explicit clinical framework. Eleven original reports addressing imaging, prognostic assessment, surgical timing, antimicrobial duration, hyperbaric oxygen, wound management, and fecal diversion were summarized. Findings were synthesized narratively because study designs, treatment selection, and outcome definitions differed. Results: Computed tomography demonstrated anatomical disease extent, although imaging findings from confirmed cases did not establish diagnostic accuracy in unselected emergency populations. Prognostic scores identified physiological disturbance without replacing clinical assessment or operative diagnosis. Earlier debridement was associated with lower mortality, including mortality of 2.6% versus 27.7% for surgery within versus after twelve hours in one cohort. Shorter antimicrobial courses following source control were not associated with worse outcomes in a retrospective study. Hyperbaric oxygen, negative pressure wound therapy, and fecal diversion produced favorable findings in selected cohorts, with substantial uncertainty from nonrandom treatment allocation. Conclusions: Emergency management prioritizes early surgical involvement, immediate broad spectrum antimicrobials, physiological stabilization, and prompt debridement. Imaging and prognostic tools support decisions without postponing source control. Adjunctive interventions require individualized selection, while prospective comparative research remains essential for defining their benefits.
Fournier's gangreneperineal soft tissue infectionemergency department managementsurgical debridement
Background/Objectives: Children with Down syndrome are at increased risk of obstructive sleep apnea (OSA), which cannot be reliably excluded by symptoms or examination. Saudi evidence remains limited. This review synthesizes international and Saudi evidence and proposes a pediatric care pathway incorporating the transition to adult services. Methods: We conducted a structured narrative review of the English-language literature identified through PubMed/MEDLINE, selected journal websites, and reference lists. The review focused on publications from January 2018 to 17 September 2026, retaining relevant earlier studies. Evidence was synthesized qualitatively without a new meta-analysis or formal risk of bias assessment. Results: Published international estimates indicate that OSA affects approximately 50–79% of children with Down syndrome. American Academy of Pediatrics guidance recommends polysomnography (PSG) at ages 3–4 years regardless of symptoms, with earlier assessment when indicated. Nonrandomized infant intervention studies suggest potential benefits but do not establish an optimal universal screening schedule. Saudi evidence includes a small earlier PSG referral cohort and more recent caregiver surveys; no nationally representative PSG-confirmed prevalence study was identified. Arabic questionnaire validation in a mixed pediatric referral cohort does not establish Down syndrome-specific diagnostic accuracy. Published treatment evidence indicates that adenotonsillectomy often improves OSA, although residual disease commonly requires objective reassessment and individualized management. Conclusions: The evidence supports age-based PSG, earlier assessment when indicated, postoperative reassessment, and individualized multidisciplinary care. Building on this evidence, we propose a Saudi pathway linking referral tracking, family-centered positive airway pressure support, and coordinated transition. Regional networks and registry development remain unevaluated implementation proposals requiring stakeholder consultation, resource assessment, and pilot testing; they do not constitute an endorsed national guideline.
Down syndromeobstructive sleep apneasleep-disordered breathingpolysomnography screening
The molecular axis underlying the epidemiologically established association between periodontitis and coronary heart disease (CHD) remains undefined at mechanistic, systems-level resolution. Classical comparative transcriptomics captures correlational gene lists but cannot reconstruct directional disease-state dynamics or locate the point along a disease-state ordering at which inflammatory resolution fails. ReNODE-Ferro integrates three public bulk transcriptomic datasets (GSE16134, periodontitis, n = 310; GSE28829, CHD staged, n = 29; GSE100927, CHD plaque, n = 104) through a nine-module biologically curated feature space (123 genes), a fully connected latent encoder, a Neural Ordinary Differential Equation (latent dim = 12) learning continuous disease-state dynamics across six biologically defined states (S0–S5), and a model-based reinforcement learning (RL) controller identifying optimal biological intervention policies in latent space. Twenty-four genes were concordantly dysregulated (FDR < 0.05) across all three datasets. Cross-disease fold-change concordance was significant (Spearman r = 0.473, p = 3.29 × 10 − 8, periodontitis vs. CHD staged). Ferroptotic vulnerability and coronary coupling co-varied with r = 0.830 ( p = 3.89 × 10 − 114). Neural ODE tipping-point analysis identified the S2→S3 metabolic strain-to-ferroptosis-primed transition as the transition carrying the highest modelled velocity, although under a held-out validation scheme the velocity profile proved comparatively flat and the location of the maximum unstable across bootstrap refits. S2 was the least responsive state to single-step intervention (3.7%), but it contains only six specimens and was the least stable cluster on resampling. RL policy optimization identified antioxidant restoration, mitochondrial quality enhancement, and pro-resolution amplification as the universal intervention triad (mean reward improvement = 0.583). Robustness analyses added at revision support and delimit these findings. Tissue of origin explained no measurable variance in the nine-module space (PERMANOVA R² < 0.001, p = 1.00) whereas disease status explained 14.0% ( p < 1 × 10⁻⁴), and the ferroptotic vulnerability–coronary coupling association persisted after adjustment for estimated cellular composition (ρ = 0.764) and within every cohort analysed separately (ρ = 0.77–0.89). An independent diffusion-pseudotime ordering reproduced the state sequence (ρ = 0.872) and placed S2 before S3 ( p = 2.4 × 10⁻¹⁰), and leave-one-cohort-out re-derivation recovered the same structure in all three folds. Against 5,000 size-matched random gene panels the curated feature space was strongly informative (empirical p = 2.0 × 10⁻⁴), although an uncurated transcriptome-wide analysis showed the ferroptotic axis to be one of several concordant programmes rather than a uniquely dominant one. Periodontitis and coronary atherogenesis share a conserved ferroptotic-metabolic resolution failure trajectory. ReNODE-Ferro provides a mechanistically grounded, interventionally actionable map of this continuum, establishing ferroptotic vulnerability as a principal and unusually tightly coupled molecular axis of this shared programme. Because all three cohorts are cross-sectional, the reconstructed trajectory is a statistical ordering rather than a demonstrated temporal or causal sequence.
Background: Emergency discharge is an established option for selected adults with uncomplicated acute diverticulitis. Treatment failure is difficult to predict accurately. This focused review examined baseline clinical, laboratory, and computed tomography predictors alongside outpatient outcomes. Methods: Original studies published through 31 May 2026 were examined for computed tomography confirmation, outpatient management, and subsequent deterioration. Ten outpatient studies were summarized descriptively. Broader prognostic cohorts were considered separately because their populations and outcomes differed from immediate emergency discharge. Results: Selected outpatient cohorts recorded low admission rates, including 2/70, 3/66, 4/155, and 4/140 patients in four studies. A randomized outpatient trial recorded hospitalization in 8/242 participants without antibiotics and 14/238 receiving antibiotics. Persistent pain and oral intolerance accounted for several treatment escalations. Imaging associations were imprecise and differed between studies. Different outcome definitions and follow-up periods restricted comparisons of failure frequencies across treatment protocols. Broader cohorts identified free fluid, female sex, elevated C-reactive protein, systemic comorbidity, vomiting, and prolonged symptoms as prognostic signals. Conclusions: Outpatient outcomes were better after structured selection and follow-up. Inflammatory burden, imaging abnormalities, and symptom persistence warrant particular attention. The data supports individualized assessment rather than a universal discharge score, with explicit separation of readmission, complicated progression, and recurrent episodes when interpreting treatment failure across different clinical settings.
acute diverticulitisuncomplicated diverticulitistreatment failurepredictors of treatment failure
Journal of Cardiovascular Development and Disease · vol. 13 (10) · 478-478
Background: Tricuspid regurgitation (TR) increases mortality but remains undertreated due to high surgical risks. Transcatheter tricuspid valve interventions (TTVI) offer safer alternatives, improving functional status and quality of life. However, many candidates for TTVI have trans-tricuspid CIED leads that may interfere with procedural imaging and device deployment and may be exposed to dislodgement, entrapment, or jailing. Evidence regarding both clinical outcomes and postprocedural CIED function in this population remains limited. Existing trial evidence for this population is scarce, requiring further safety analysis. To our knowledge, this is the first meta-analysis to address the comparative risk of complications and residual TR in patients with vs. without CIEDs. Methods: We searched for relevant articles up to March 2026 from PubMed, Scopus, Cochrane Library, and Web of Science. Two independent reviewers extracted data from the selected studies, including baseline information, outcomes, comorbidities, hospitalization metrics, TR severity, and complications. All data analyses were performed using R version 4.4.1. Results: Ten studies comprising 5415 patients were included. Nine comparative studies contributed to the quantitative synthesis, whereas one single-arm study contributed only to the narrative synthesis of CIED-specific mechanical and electrical outcomes. In patients undergoing TTVI, across two studies, patients with CIEDs had a nominally lower risk of single-leaflet device attachment (RR 0.34, 95% CI 0.12–0.94; nominal p = 0.037); however, this exploratory finding should be considered hypothesis-generating. However, no statistically significant differences were observed between groups for cardiovascular death (RR 1.30, p = 0.815), device embolization (RR 1.62, p = 0.666), device malposition (RR 1.10, p = 0.909), stroke (RR 0.52, p = 0.335), hospitalization for heart failure (RR 1.02, p = 0.931), in-hospital mortality (RR 1.02, p = 0.959), major adverse events (RR 0.74, p = 0.635), major bleeding (RR 0.70, p = 0.187), or residual tricuspid regurgitation of mild (RR 0.98, p = 0.686) or moderate severity (RR 1.01, p = 0.646). CIED-specific outcomes were reported heterogeneously. Lead function was generally preserved after T-TEER in carefully selected patients, whereas studies of TTVR with jailed leads reported lead failure or malfunction ranging from 5.8% to 21% in individual cohorts. Conclusions: Among the comparative outcomes available for quantitative pooling, no statistically significant differences were detected between patients with and without CIEDs for most procedural and postprocedural outcomes. However, CIED-specific risks differed according to the intervention. Lead function was generally preserved after T-TEER in carefully selected patients, whereas lead jailing during TTVR was associated with clinically relevant lead malfunction in some cohorts. Therefore, the absence of significant differences in pooled clinical outcomes should not be interpreted as evidence that TTVI does not affect CIED function.
OBJECTIVE: Aims of the study were to evaluate the diagnostic performance of abdominal ultrasonography, specifically its positive predictive value, in children younger than 36 months presenting with suspected intussusception to the emergency department of a major tertiary care center in Saudi Arabia and to describe the associated clinical and sonographic features. METHODS: This retrospective study reviewed the medical records and radiological findings of 150 pediatric patients aged less than 36 months who presented with suspected intussusception to the emergency department in a major tertiary care center in Saudi Arabia between 2005 and 2015. Ultrasound was used as the initial diagnostic modality, and findings were confirmed using contrast enema, computed tomography scan, or intraoperative findings when applicable. RESULTS: Out of 150 suspected cases, 36 patients (24.0%) were confirmed to have intussusception. All 36 ultrasound-positive cases were subsequently confirmed by contrast enema, computed tomography, or surgery, giving a positive predictive value of 100% (36/36). Because the 114 ultrasound-negative patients were classified on the basis of clinical course rather than an independent reference standard, sensitivity, specificity, and negative predictive value could not be validly estimated and are not reported. Vomiting and bloody stool were significantly associated with confirmed diagnosis; no significant association was found with gender. CONCLUSION: In this single-center retrospective cohort, a positive abdominal ultrasound reliably predicted confirmed intussusception, supporting its established role as the first-line imaging modality for suspected pediatric intussusception. Although these regional data add local confirmation but given the retrospective design and the absence of an independent reference standard for ultrasound-negative cases, they should be interpreted with caution.
BACKGROUND: As the foremost cause of irreversible vision loss around the world, glaucoma continues to be the leading factor behind irreversible blindness. Even with progress in diagnostic tools, surgical techniques, and additional therapies, the disease continues to be problematic because of its asymptomatic onset and the partial effectiveness of pressure-reducing treatments. The overall role of significant publications in guiding glaucoma research has not been thoroughly evaluated. METHODS: A bibliometric study was carried out to determine the 50 articles on glaucoma with the highest citation counts, with searches conducted in the Web of Science database. Four reviewers independently screened the articles. The extracted information covered authorship, country of origin, journal name, study design, level of evidence, citation counts, and thematic focus. Citation and co-occurrence mapping were applied. RESULTS: The 50 most-cited articles accrued 4054 citations (mean: 81.1), peaking in the 2000s (42%). The US (52%) and UK (30%) led contributions, primarily in Ophthalmology and British Journal of Ophthalmology. Level II evidence predominated (44%), followed by Level IV evidence (38%). Retrospective cohort studies comprised the most common study design (36%), followed by case series (30%), while randomized controlled trials represented 12% of the included studies. Key themes included diagnostic integration, trabeculectomy, minimally invasive surgery (MIGS), and refractory disease management. CONCLUSION: Most-cited glaucoma-management literature was characterized by retrospective study designs and representation of both traditional filtration surgery and emerging device-based approaches, including MIGS. These findings describe patterns of scholarly attention within highly cited glaucoma-management literature and should not be interpreted as trends across the entire field or as evidence of comparative clinical effectiveness.
OBJECTIVE: The aim of this study was to investigate the relationship between perceived stress and sleep quality with glycemic blood levels in T2DM patients in Riyadh. SUBJECT AND METHODS: This cross-sectional study evaluated a total of 309 patients diagnosed with type 2 diabetes mellitus in Riyadh, Saudi Arabia. The study comprised an initial validation and Arabic translation phase involving 160 participants, followed by an analytical phase focusing on 149 adult patients. To investigate the impact of psychosocial and metabolic factors on glycemic control (hemoglobin A1c [HbA1c]), data were collected using the Pittsburgh Sleep Quality Index (PSQI) and the Perceived Stress Scale (PSS-10), alongside clinical metrics such as body mass index (BMI) and dyslipidemia extracted from medical records. A multivariable linear regression model was utilized to identify independent factors associated with glycemic regulation within the local population. RESULTS: The multivariable regression model demonstrated robust explanatory power (adjusted R2 = 0.726, p < 0.001). Traditional risk factors, specifically elevated BMI (β = 0.448, p < 0.001) and dyslipidemia (β = 0.304, p < 0.001), were significantly associated with higher HbA1c levels. Notably, poor sleep quality emerged as a significant independent factor associated with elevated HbA1c (β = 0.261, p < 0.001), whereas perceived stress did not exhibit a significant correlation. Conversely, physical activity demonstrated a significant protective effect, correlating with lower HbA1c (β = -0.271, p < 0.001). CONCLUSION: Poor sleep quality, rather than perceived psychological stress, is a primary factor independently associated with hyperglycemia in this patient cohort. These findings suggest that standard diabetes care should integrate formal sleep assessments alongside patient care management.
type 2 diabetesperceived stresssleep qualityglycemic control
Annals of Middle Eastern Medicine · vol. 2 (3) · 302-311
This systematic review and meta-analysis evaluated preoperative patient factors associated with adverse outcomes after primary total knee arthroplasty (TKA). PubMed and Crossref were searched from 2010 to 2025 according to PRISMA guidance, and the protocol was registered in PROSPERO (CRD420261297849). Eligible studies included adults undergoing primary TKA and reported diabetes mellitus, hypertension, obesity, morbid obesity, or sex in relation to readmission, revision surgery, or deep infection. Random-effects generic inverse variance meta-analyses were performed using odds ratios from adjusted models when available; unadjusted or calculated estimates were used only when adjusted estimates were unavailable. Twelve cohort studies including 1,586,680 patients were included. Diabetes mellitus was associated with higher odds of readmission (OR 1.17, 95% CI 1.05-1.30) and revision surgery (OR 1.17, 95% CI 1.03-1.32). Morbid obesity (BMI ≥40 kg/m²) was associated with readmission, revision surgery, and deep infection. Male sex was associated with readmission and revision surgery, while non-morbid obesity and hypertension were not consistently associated with adverse outcomes. These findings support preoperative risk stratification and optimization for diabetes and morbid obesity before elective TKA. Interpretation should remain cautious because included studies were observational and heterogeneity was substantial in several analyses.
total knee arthroplastypreoperative risk factorsadverse outcomesdiabetes mellitus
Abstract Background Master's programmes in Health Professions Education (HPE) have proliferated globally, yet evidence of their outcomes in low-resource, conflict-affected settings remains scarce. The University of Gezira Master of Health Professions Education (MHPE) one of the earliest postgraduate HPE qualifications in sub-Saharan Africa, has not been empirically evaluated. Objectives To evaluate the perceived impact of the Gezira MHPE on graduates' educational competencies, scholarly engagement, and professional identity, and to examine whether outcomes varied by cohort, delivery mode, profession, and workplace location. Methods A cross-sectional, retrospective pre-post census survey was administered to all 152 confirmed graduates of the Gezira MHPE (2010 to 2025), of whom 120 participated (76.4%). A validated, adapted instrument measured 12 Academy of Medical Educators-aligned competency items, five scholarly engagement items, and six professional identity items, rated on 5-point scales. Non-parametric statistics were applied throughout; two open-ended questions underwent inductive thematic analysis following Braun and Clarke's framework Results All 12 competency domains improved significantly ( p < .001; r = 0.64 to 0.81), with the largest gains in needs assessment and assessment design. A marked consumer-to-producer transition in scholarly engagement was documented across all five activities ( p < .001; r = 0.85 to 0.87). Professional identity was high overall (composite median 4.08/5.00), though peer recognition was markedly lower (median 3.0) and structurally distinct in factor analysis. Sudan-based graduates reported significantly lower identity scores than diaspora-based peers (median 2.92 vs 4.00; p = .005) despite equivalent competency and scholarship gains. Outcomes were consistent across cohorts, delivery modes, and professional backgrounds. Conclusions The Gezira MHPE is associated with competency and scholarly gains comparable to programmes in high-income settings. Professional identity consolidation is context-sensitive: post-qualification institutional environments determine whether programme gains translate into recognised educator identity. Investment in programme quality is necessary but insufficient — the conditions enabling qualified graduates to be recognised and sustained as educational leaders are equally consequential
health professions educationgraduate competenciesacademic engagementprofessional identity